EFFICACY AND SAFETY OF PIDOTIMOD IN THE TREATMENT OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN
<em>The immunomodulating activity of pidotimod (imunorix) was evaluated in a doublebblind, placebobcontrolled, randomized, multicentre trial, on 120 pediatric patients affected by recurrent respiratory infections. Antibiotic therapy and time of hospitalization were shorter in the patients taki...
Main Authors: | G. Caramia, E. Clemente, R. Solli, V. Mei, R. Cera, V. Carnelli, V. Venturoli, A. Corsini |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2008-01-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/1371 |
Similar Items
-
EFFICACY AND SAFETY OF PIDOTIMOD IN THE TREATMENT OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN
by: G. Caramia, et al.
Published: (2008-04-01) -
Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study
by: Diletta Valentini, et al.
Published: (2020-03-01) -
PIDOTIMOD IN TREATMENT OF CHILDREN WITH ACUTE RESPIRATORY INFECTION WITH CONCOMITANT RECURRENT OBSTRUCTIVE SYNDROME
by: E. E. Lokshina, et al.
Published: (2011-01-01) -
PIDOTIMOD IN TREATMENT OF CHILDREN WITH ACUTE RESPIRATORY INFECTION WITH CONCOMITANT RECURRENT OBSTRUCTIVE SYNDROME
by: E. E. Lokshina, et al.
Published: (2011-01-01) -
Pidotimod – Current Role and Evidence
by: Yash Sanjay Kedia, et al.
Published: (2024-11-01)